TREACE MEDICAL CONCEPTS, INC. (TMCI) — insider trading
Health Care · NASDAQ
TREACE MEDICAL CONCEPTS, INC. (TMCI) has 26 reported SEC Form 4 insider transactions in our data, including 14 open-market purchases among the most recent 26 (latest 2026-09-30).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | Elder Scot Michael | Officer (Chief Legl & Comp Off, CorpSec) | Shares withheld for taxes / exercise cost | 25,457 | — | $0 | Form 4 |
| 2026-08-24 | Treace John T. | Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | 11,000 | $4.34 | $47.7K | Form 4 |
| 2026-08-21 | Treace John T. | Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | 5,000 | $4.35 | $21.7K | Form 4 |
| 2026-08-20 | Treace John T. | Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | 39,944 | $4.44 | $177.2K | Form 4 |
| 2026-08-09 | Elder Scot Michael | Officer (Chief Legl & Comp Off, CorpSec) | Shares withheld for taxes / exercise cost | 16,253 | — | $0 | Form 4 |
| 2026-08-09 | Hair Mark | Officer (Chief Financial Officer) | Shares withheld for taxes / exercise cost | 37,102 | — | $0 | Form 4 |
| 2026-08-09 | Scanlan Sean F. | Officer (Chief Innovation Officer) | Shares withheld for taxes / exercise cost | 9,814 | — | $0 | Form 4 |
| 2026-06-11 | Treace John T. | Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | 9,891 | $4.04 | $40.0K | Form 4/A |
| 2026-06-11 | Treace John T. | Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | 22,887 | $4.04 | $92.5K | Form 4 |
| 2026-06-10 | Treace John T. | Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | 14,715 | $4.02 | $59.2K | Form 4/A |
| 2026-06-10 | Treace John T. | Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | 29,430 | $4.02 | $118.4K | Form 4 |
| 2026-06-01 | Treace John T. | Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | 50,000 | $3.56 | $177.9K | Form 4 |
| 2026-05-28 | Treace John T. | Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | 61,202 | $3.02 | $184.8K | Form 4 |
| 2026-05-27 | Treace John T. | Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | 49,810 | $2.87 | $143.2K | Form 4 |
| 2026-05-26 | Treace John T. | Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | 4,508 | $2.79 | $12.6K | Form 4 |
| 2026-05-19 | Hanna Betsy | Director | Grant / award / vesting | 30,000 | — | $0 | Form 4 |
| 2026-05-19 | HAMILTON LAWRENCE W | Director | Grant / award / vesting | 30,000 | — | $0 | Form 4 |
| 2026-05-19 | Jain Deepti | Director | Grant / award / vesting | 30,000 | — | $0 | Form 4 |
| 2026-05-19 | Berry Lance A | Director | Grant / award / vesting | 30,000 | — | $0 | Form 4 |
| 2026-05-19 | Kiernan Jane E | Director | Grant / award / vesting | 30,000 | — | $0 | Form 4 |
| 2026-05-19 | BAKEWELL JOHN K | Director | Grant / award / vesting | 30,000 | — | $0 | Form 4 |
| 2026-05-14 | Treace John T. | Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | 61,750 | $2.62 | $161.5K | Form 4 |
| 2026-05-13 | Treace John T. | Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | 49,013 | $2.46 | $120.5K | Form 4 |
| 2026-05-12 | Treace John T. | Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | 43,000 | $2.17 | $93.5K | Form 4 |
| 2026-04-17 | Hair Mark | Officer (Chief Financial Officer) | Shares withheld for taxes / exercise cost | 11,547 | — | $0 | Form 4 |
| 2026-04-01 | Hair Mark | Officer (Chief Financial Officer) | Grant / award / vesting | 100,000 | — | $0 | Form 4 |
Ask the chat about TMCI's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: TREACE MEDICAL CONCEPTS, INC. (TMCI).
Last updated 2026-09-30 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.